Chris Worle - Hargreaves Lansdown Chief Officer
| HL Stock | 1,088 0.50 0.05% |
Executive
Chris Worle is Chief Officer of Hargreaves Lansdown plc
| Age | 42 |
| Address | One College Square South, Bristol, United Kingdom, BS1 5HL |
| Phone | 44 1179 009 000 |
| Web | https://www.hl.co.uk |
Hargreaves Lansdown Management Efficiency
The company has return on total asset (ROA) of 0.1711 % which means that it generated a profit of $0.1711 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3846 %, meaning that it generated $0.3846 on every $100 dollars invested by stockholders. Hargreaves Lansdown's management efficiency ratios could be used to measure how well Hargreaves Lansdown manages its routine affairs as well as how well it operates its assets and liabilities. At present, Hargreaves Lansdown's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 1.5 B, whereas Non Currrent Assets Other are forecasted to decline to about 427.5 K.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Adv | Surgical Science Sweden | 56 | |
| Christine CPA | Mereo BioPharma Group | 43 | |
| MD BSc | Oncimmune Holdings plc | N/A | |
| James MD | Oncimmune Holdings plc | N/A | |
| Charlotte Almberg | Coor Service Management | N/A | |
| Fiona Bor | Mereo BioPharma Group | N/A | |
| Suba Krishnan | Mereo BioPharma Group | 59 | |
| Markus Danielson | Coor Service Management | N/A | |
| John Lewicki | Mereo BioPharma Group | 72 | |
| BSc FRCP | Oncimmune Holdings plc | N/A | |
| Matthew Hall | Oncimmune Holdings plc | N/A | |
| Cla Rosenfeld | Oncimmune Holdings plc | N/A | |
| Cameron Barnard | Oncimmune Holdings plc | N/A | |
| Tom Englund | Surgical Science Sweden | 48 | |
| Jeffrey Berkley | Surgical Science Sweden | 55 | |
| Bo Kara | Mereo BioPharma Group | N/A | |
| Sofia Nilsson | Coor Service Management | N/A | |
| Anna Ahlberg | Surgical Science Sweden | 54 | |
| BA FCA | Oncimmune Holdings plc | 56 | |
| Daniel Evestedt | Surgical Science Sweden | 47 | |
| Inbal MazorBadichi | Surgical Science Sweden | 55 | |
Management Performance
| Return On Equity | 0.38 | ||||
| Return On Asset | 0.17 |
Hargreaves Lansdown plc Leadership Team
Elected by the shareholders, the Hargreaves Lansdown's board of directors comprises two types of representatives: Hargreaves Lansdown inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hargreaves. The board's role is to monitor Hargreaves Lansdown's management team and ensure that shareholders' interests are well served. Hargreaves Lansdown's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hargreaves Lansdown's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dan Olley, CEO Director | ||
| Chris Worle, Chief Officer | ||
| Penelope Chapman, General Secretary | ||
| Toby Vaughn, Chief Officer | ||
| Amy Stirling, CFO Director | ||
| Lee Gardhouse, Chief Officer | ||
| Rob BSc, Risk Director | ||
| Mark Dampier, Head Research | ||
| Richard Hebdon, Chief Officer | ||
| Gary Logan, Chief Officer | ||
| Christopher ACA, CEO Director | ||
| Matt Bonetti, Head Division | ||
| CPA CBE, CoFounder | ||
| Peter Hargreaves, CoFounder | ||
| David James, Brand Marketing | ||
| James ACA, Head Controller |
Hargreaves Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hargreaves Lansdown a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.38 | ||||
| Return On Asset | 0.17 | ||||
| Profit Margin | 0.38 % | ||||
| Operating Margin | 0.50 % | ||||
| Current Valuation | 4.53 B | ||||
| Shares Outstanding | 474.16 M | ||||
| Shares Owned By Insiders | 29.35 % | ||||
| Shares Owned By Institutions | 63.09 % | ||||
| Price To Book | 6.33 X | ||||
| Price To Sales | 6.75 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Hargreaves Stock
Hargreaves Lansdown financial ratios help investors to determine whether Hargreaves Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hargreaves with respect to the benefits of owning Hargreaves Lansdown security.